VIVEbiotech participates in the European MAGIC project
The MAGIC consortium is committed to making a meaningful impact on the lives of individuals affected by muscular dystrophies.
VIVEbiotech participates in the European MAGIC project
Abstract submission deadline for the ETRS-SPCE annual meeting has been extended to July 16
Förderstiftung MHH plus awards Johann Georg Zimmermann Medal to LIT scientist Hinrich Abken
Hildegard Büning first winner of the Exceptional Service Award
13TH STEM CELL CLONALITY AND GENOME STABILITY RETREAT
Seppo Yla-Herttuala winner of 2023 Outstanding Achievement Award
GLOBAL AWARDS FOR RESEARCH IN DMD-AWARD
INTERNATIONAL PRIMARY IMMUNODEFICIENCIES CONGRESS
WADA invites applications for research projects on the development of gene doping detection methods
JOIN SFTCG'S WEBINAR SERIES ON GENE EDITING AND GENE THERAPY
ESGCT 2022 HEADLINE NUMBERS
ESGCT SUPPORTING MASTERS STUDENTS
SCIENTIFIC CALL FOR PROPOSALS AFM-TELETHON 2023
IMPORTANT NEWS TO SHARE WITH US?
FIRST CONDITIONAL MARKETING AUTHORIZATION APPROVAL IN THE EU FOR HEMOPHILIA "A" GENE THERAPY
NEW EUROPEAN CONSORTIUM - AGORA
ERC HORIZON EUROPE 2023 SUBMISSION DATES
REVIEW ARTICLE: TOWARDS ACCESS FOR ALL
IN MEMORY OF DR. MANFRED SCHMIDT
REVIEW ON EX VIVO HSC GENE THERAPY FOR NATURE REV GENETICS